# Tulex Pharmaceuticals Inc. – FDA Inspection, Nov 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/tulex-pharmaceuticals-inc/a0867f8e-3b5f-4fc5-ad03-788d5b196185
Source feed: FDA_Inspections

> FDA inspection 1031819 of Tulex Pharmaceuticals Inc., November 21, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031819
- Company Name: Tulex Pharmaceuticals Inc.
- Inspection Date: 2017-11-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1264812 - 2025-03-24](https://www.keypedia.com/records/fda_inspections/tulex-pharmaceuticals-inc/3085aa66-b7a0-4815-9e58-5d1875897b55)
- FDA Inspection 1256966 - 2024-12-05
- FDA Inspection 1232755 - 2024-02-29
- FDA Inspection 1129002 - 2020-08-14
- FDA Inspection 1053140 - 2018-04-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)

Company: https://www.keypedia.com/companies/tulex-pharmaceuticals-inc/e9839d9b-b973-49c3-916a-4ca187d606dd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
